Closed
Generic Drugs - Injections/Infusions
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- Value
- £47,520,000
- Published
- 28 Aug 2026
- Deadline
- 7 Sept 2026
- Procedure
- Not stated
- Category
- 33600000 — Pharmaceutical products
- Location
- UKL, United Kingdom
- Notice reference
- 082307-2026
Requirements summary
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust), on behalf of All Wales Health Boards and Trusts, is planning a goods contract for generic injection and infusion drugs. The notice is a preliminary market engagement notice with an estimated value of GBP 47.52m gross (GBP 39.6m net), a contract period from 1 July 2027 to 30 June 2030, and an option to extend to 30 June 2031.
Key requirements
- Supply of generic injectable and infusion drugs to NHS Wales health boards and trusts
- Estimated value of GBP 47.52m gross (GBP 39.6m net), with renewal option
- Contract period 1 July 2027 to 30 June 2030, extendable to 30 June 2031
- Delivery within the United Kingdom (GB)
- Lot suitability flagged for SMEs
- Supplier engagement via contact Rachel Nelson before the tender is published; future notice expected 8 September 2026
Similar open notices
- Generic Drugs - Oral LiquidsNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- Generic Drugs - Oral LiquidsNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- NHS National Framework Agreement for Macitentan & Cladribine TabletsNHS England
- Injection Equipment ParaphernaliaThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy ServicesUniversity Hospitals of Derby and Burton NHS Foundation Trust